Phase I Dose Escalation Trial of Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis
Phase of Trial: Phase I
Latest Information Update: 30 Dec 2016
At a glance
- Drugs Pertuzumab (Primary) ; Trastuzumab
- Indications Brain metastases; Breast cancer; Male breast cancer
- Focus Adverse reactions
- 23 Dec 2016 Planned End Date changed from 1 Aug 2018 to 1 Aug 2019.
- 23 Dec 2016 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2019.
- 21 Jun 2016 Status changed from not yet recruiting to recruiting.